Sigma Life Science and SwitchGear Genomics announce a joint project to develop and distribute a novel microRNA (miRNA) target reporter system. Combining SwitchGear Genomics' expertise with Sigma's versatile ....
Detailed pictures are published showing how an experimental antibiotic can kill bacteria already resistant to existing treatments. The findings could ultimately help scientists to develop new antibiotics ....
Life Technologies and University of California at San Diego (UCSD) Moores Cancer Center announces a partnership to use Solid 4 genomic analysis technology in a research program to study chronic lymphocytic ....
Pure Bioscience announces that based on encouraging preclinical data it has granted two product-specific licenses to pharmaceutical development partner FTA Bioscience for development of a silver dihydrogen ....
miRagen Therapeutics announces the publication of data demonstrating the essential role of microRNA-451 (miR-451) in the regulation of erythropoiesis, the process of red blood cell production in the body. ....
Carotech announces that study shows the potential of Tocomin as a chemopreventive agent against prostate cancer. Published in the August issue of Nutrition and Cancer, researchers at Rutgers, The State ....
Genedata, announces the release of PatentExplorer, an interdisciplinary software tool for assessing the patent situation of novel biomolecules and targets. Part of the Genedata Phylosopher biological ....
Thomson Reuters announced that it has launched The Outpartnering Registry, a resource platform designed to help biotechnology, pharmaceutical and academic organisations find partnering opportunities around ....
A shift in the life science market has begun to steer cell culture scientists to re-evaluate their use of native transferrin and iron chelators to pursue recombinant alternatives. Transferrin regulates ....
Researchers at Cleveland Clinic's Lerner Research Institute say they have developed prototype vaccine to prevent breast cancer. The research can lead to prevention in women over age 40 and those at high ....